Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:831-837
Published online before print February 7, 2008, doi: 10.1161/STROKEAHA.107.494518
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/3/831    most recent
STROKEAHA.107.494518v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, D. T.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Thrombolysis

(Stroke. 2008;39:831.)
© 2008 American Heart Association, Inc.


Original Contributions

Impact of Restricting Enrollment in Stroke Genetics Research to Adults Able to Provide Informed Consent

Donna T. Chen, MD, MPH; L. Douglas Case, PhD; Thomas G. Brott, MD; Robert D. Brown, Jr, MD; Scott L. Silliman, MD; James F. Meschia, MD; Bradford B. Worrall, MD, MSc for the ISGS Investigators*

From the Department of Public Health Sciences (D.T.C., B.B.W.), the Department of Psychiatric Medicine (D.T.C.), the Department of Neurology (B.B.W.), and the University of Virginia Center for Biomedical Ethics (D.T.C.), University of Virginia, Charlottesville, Va; the Department of Public Health Sciences (L.D.C.), Wake Forest University, Winston-Salem, NC; the Department of Neurology (T.G.B., J.F.M.), Mayo Clinic, Jacksonville, Fla; the Department of Neurology (R.D.B.), Mayo Clinic, Rochester, Minn; and the Department of Neurology (S.L.S.), University of Florida, Jacksonville, Fla.

Correspondence to James F. Meschia, Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224. E-mail meschia.james{at}mayo.edu

Background and Purpose— The extent of potential consent bias in observational studies elucidating genetic and environmental contributions to ischemic stroke is largely unknown. The purpose of this study was to assess differences in stroke cohort characteristics between those who provided informed consent and those whose enrollment was authorized by surrogate decision makers.

Methods— The Ischemic Stroke Genetics Study (ISGS) is a prospective, 5-center, case-control study of first-ever ischemic stroke. Demographic, clinical, and stroke characteristics were compared between cases enrolled by self versus by surrogate. Data from one site that limits enrollment only to those able to self-consent were also analyzed to compare those who enrolled with those not able to consent.

Results— Overall, 10% (54 of 517) were enrolled using surrogate authorization. Self-consented and surrogate-authorized cases did not differ significantly in age, sex, or conventional risk factors. Surrogate-authorized cases had significantly more severe stroke deficits, larger infarcts, and infarcts localizing to left supratentorial regions. Similarly, at the site restricting enrollment, stroke severity and characteristics differed between self-consented individuals and those otherwise eligible but unable to provide consent.

Conclusions— Failure to permit surrogate authorization in genetic studies of ischemic stroke may skew enrollment toward less severe strokes caused by smaller infarcts. This potential consent bias may undermine the ability to identify genetic determinants of risk and severity and suggests that surrogate enrollment in these studies can be ethically justifiable.


Key Words: consent bias • ischemia • research ethics • stroke




This article has been cited by other articles:


Home page
StrokeHome page
P. M.W. Bath and A. R. Watson
Need for Ethics Approval and Patient Consent in Clinical Research
Stroke, May 1, 2009; 40(5): 1555 - 1556.
[Full Text] [PDF]


Home page
NeurologyHome page
D. T. Chen
Why surrogate consent is important: A role for data in refining ethics policy and practice
Neurology, November 11, 2008; 71(20): 1562 - 1563.
[Full Text] [PDF]


Home page
StrokeHome page
D. T. Chen, J. F. Meschia, T. G. Brott, R. D. Brown, B. B. Worrall, and for the SWISS investigators
Stroke Genetic Research and Adults With Impaired Decision-Making Capacity: A Survey of IRB and Investigator Practices
Stroke, October 1, 2008; 39(10): 2732 - 2735.
[Abstract] [Full Text] [PDF]